NCT06955754

A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food

Relative Bioavailability of Three Different Oral Formulations of BI 764198 Including the Investigation of Food Effect on the Tablet Formulation in Healthy Male and Female Subjects (an Open-label, Randomised, Four-way Crossover Trial)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This trial aims to investigate the relative bioavailability of three different oral formulations of BI 764198 and how this is influenced by food.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	BI 764198, formulation 1	BI 764198, formulation 1
DRUG	BI 764198, formulation 2	BI 764198, formulation 2
DRUG	BI 764198, formulation 3	BI 764198, formulation 3

Timeline

• Start date: 2025-05-20
• Primary completion: 2025-06-26
• Completion: 2025-07-14
• First posted: 2025-05-02
• Last updated: 2025-07-18

Locations

1 site across 1 country: Germany